Cell-Free DNA Market is Estimated to grow at a CAGR of 8.3% during the forecast period
The market for cell-free DNA market was estimated to be worth USD 169.6 million globally in 2022, and over the course of the forecast period, a CAGR of 8.3% is predicted. The increased incidence of cancer and the growing number of government efforts have led to a rise in the use of cell-free DNA isolation and extraction kits. The need for non-invasive diagnostic techniques, like CFDNA testing, which aids in early disease diagnosis, has increased due to the rising prevalence of genetic disorders. Accuracy is increasing thanks to advancements in bioinformatics and sequencing technology. The market is expanding due to rising healthcare costs and patients' growing knowledge of the condition. Better, more creative testing methods are expected to enter the market as technology develops, boosting competitiveness. The market is expanding dramatically due to rising healthcare costs. Rigid regulatory criteria, the high cost of automated instruments, and the preservation of genomic data ...